Results 81 to 90 of about 68,824,737 (161)

Increase of plasma interleukin-31 levels associated with coronary artery lesion formation in Kawasaki disease.

open access: yes, 2014
Distribution of plasma levels of interleukin-31 (IL-31) before Intravenous immunoglobulin (IVIG) treatment (KD1), within 3 days after IVIG treatment (KD2) and at least 3 weeks after IVIG treatment (KD3).
Wei-Chiao Chang (106725)   +5 more
core   +1 more source

IL-33/IL-31 Axis: A Potential Inflammatory Pathway

open access: yesMediators of Inflammation, 2018
Cytokines play an important role in the regulation of the immune system (adaptive and innate). Given their importance in proinflammatory processes, cytokines have been used for understanding the pathogenesis and as biomarkers in many diseases.
Eleonora Di Salvo   +4 more
doaj   +1 more source

Anti-atopic dermatitis effect of fraxinellone via inhibiting IL-31 in vivo and in vitro

open access: yesHeliyon
Chronic recurrent itch and skin inflammation are prominent features of atopic dermatitis (AD), which is closely related to the immune response driven by T-helper type 2 (Th2) cells.
Niuniu Yang   +6 more
doaj   +1 more source

Evaluation of Interleukin-31 Serum Levels in Patients with Chronic Kidney Disease on Hemodialysis with and without Uremic Pruritus

open access: yesمجلة كلية الطب
Background: Interleukin-31 has been linked with developing and maintaining pruritus in various dermatological and non-dermatological diseases. Objectives: To evaluate interleukin-31 serum levels in hemodialysis patients with and without uremic ...
Mustafa Sh. Abdulqahar, Ali A. Kasem
doaj   +1 more source

The Relationship Between Serum Interleukin-31 Levels and Chronic Kidney Disease-Associated Pruritus in Patients Undergoing Hemodialysis

open access: yesActa Medica Indonesiana
Background: Chronic kidney disease-associated pruritus (CKD-aP) has been linked to immune dysregulation, including elevated interleukin-31 (IL-31) levels.
I Gede Yasa Asmara   +7 more
doaj   +4 more sources

Nemolizumab for the treatment of atopic dermatitis

open access: yesJournal of Dermatological Treatment
Purpose Atopic dermatitis (AD) is a common, heterogeneous inflammatory skin disease characterized by chronic or relapsing eczematous lesions and intense pruritus, leading to reduced quality of life and increased mental health burden.
Erica Rodrigues   +4 more
doaj   +1 more source

Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria

open access: yes, 2017
Chronic spontaneous urticaria (CSU) is considered in a subset of patients to be an autoimmune disorder. Interleukin(IL)-17, IL-31, and IL-33 are involved in some immune response. The aim of this study was to quantify plasma IL-17, IL-31, and IL-33 levels
Chunbo Liu   +4 more
core   +1 more source

MicroRNA-31 negatively regulates Interleukin-34 expression in vitro

open access: yes, 2019
Interleukin-34 (IL-34) is a recently discovered cytokine that promotes tissue macrophage maturation and differentiation. We previously found that 1α,25-Dihydroxyvitamin D3 up-regulated IL-34 expression in SH-SY5Y neural cells.
Dong, Y (15611300)   +15 more
core  

Home - About - Disclaimer - Privacy